StockData
Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc. (ASMB) stock

ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.50+1.21 (+5.68%)

Close on Nov 17, 2026Market cap $458.11MP/E –Yield –

Assembly Biosciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Assembly Biosciences's enterprise value was $123.65M on Nov 11, 2026, against $365.12M a year earlier. Over the last 5 years it ranged from -$93.34M to $365.12M, with a median of -$13.20M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$123.65M-59.5%
2025Dec 31, 2025$305.34M+5640.8%
2024Dec 31, 2024$5.32M–
2023Dec 29, 2023-$3.06M–
2022Dec 30, 2022-$45.62M–
2021Dec 31, 2021-$71.21M–
2020Dec 31, 2020-$38.74M-110.4%
2019Dec 31, 2019$372.44M+8.9%
2018Dec 31, 2018$341.99M-52.5%
2017Dec 29, 2017$720.44M+378.2%
2016Dec 30, 2016$150.65M+137.0%
2015Dec 31, 2015$63.57M+26.2%
2014Dec 31, 2014$50.36M+7.8%
2013Dec 31, 2013$46.71M+966.9%
2012Dec 31, 2012$4.38M-90.5%
2011Dec 30, 2011$46.06M–

More Assembly Biosciences figures

See a number that looks wrong?